Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Warts × Exercise × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Motor Activity 203 Breast Neoplasms 110 Neoplasms 89 Prostatic Neoplasms 32 Fatigue 27 Obesity 22 Colorectal Neoplasms 20 Lung Neoplasms 15 Colonic Neoplasms 15 Polycystic Ovary Syndrome 13 Ovarian Neoplasms 12 Precursor Cell Lymphoblastic Leukemia-Lymphoma 10 Head and Neck Neoplasms 10 Rectal Neoplasms 9 Lymphoma 9 Lymphedema 9 Hematologic Neoplasms 9 Multiple Myeloma 8 Brain Neoplasms 8 Weight Loss 7 Pancreatic Neoplasms 7 Insulin Resistance 7 Cardiotoxicity 7 Carcinoma, Non-Small-Cell Lung 7 Leukemia 6 Cognitive Dysfunction 6 Sarcopenia 5 Peripheral Nervous System Diseases 5 Overweight 5 Lymphoma, Follicular 5

Interventions

Cryotherapy 10 resiquimod 5 PRA1 protein, Candida albicans 4 Cantharidin 4 Salicylic Acid 3 Cholecalciferol 3 plerixafor 2 VP-102 2 Tuberculin 2 Photochemotherapy 2 Percutaneous Collagen Induction 2 N-phenylacetoaminomethylene-DL-p-nitrophenylalanine 2 Measles-Mumps-Rubella Vaccine 2 Lasers 2 3-ingenyl angelate 2 2-Propanol 2 methyl 5-aminolevulinate 1 leupin 1 human papillomavirus vaccine, L1 type 16, 18 1 green tea extract polyphenone E 1 ethyl pyruvate 1 compound W 1 ammonium trichloro(dioxoethylene-O,O'-)tellurate 1 Zinc Sulfate 1 Zinc 1 Vaccination 1 Trichloroacetic Acid 1 Sugars 1 Solutions 1 Sodium Chloride 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03691831 2020-10-27

A Study of A-101 Topical Solution for the Treatment of Common Warts

Aclaris Therapeutics, Inc.

Phase 3 Completed

502 enrolled 22 charts

Warts

Data powered by HemOnc (CC BY 4.0) Colophon ⚡